HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lymphocyte/monocyte ratio in osteoarticular tuberculosis in children: a haematological biomarker revisited.

AbstractINTRODUCTION:
*Work attributed to Department of Pediatric Orthopaedics, Chacha Nehru Bal Chikitsalaya, Geeta Colony, Delhi-110031(India)This study tested the hypothesis whether the lymphocyte/monocyte ratio (L/M ratio) altered significantly during treatment of paediatric osteoarticular tuberculosis (OATB) for it to be a useful monitor of the response to therapy.
MATERIAL AND METHODS:
Thirty immunocompetent paediatric patients with OATB treated with 6 months of uninterrupted multidrug anti-tubercular treatment with resultant clinical and radiological healing of the lesion were included. Haemoglobin, total leucocyte, monocyte and lymphocyte count, and erythrocyte sedimentation rate (ESR) were collected at 0, 2 and 6 months, and were analysed.
RESULTS:
The L/M ratio altered from high (11) at the start of treatment towards normalisation (9) at 2 months and (7.7) at 6 months. There was no correlation with declining ESR levels.
CONCLUSIONS:
The L/M ratio may have potential as an effective biomarker response.
AuthorsAnil Agarwal, Mohd Shafi Bhat, Anubrat Kumar, Abbas Shaharyar, Madhusudhan Mishra, Rajeev Yadav
JournalTropical doctor (Trop Doct) Vol. 46 Issue 2 Pg. 73-7 (Apr 2016) ISSN: 1758-1133 [Electronic] England
PMID26503639 (Publication Type: Evaluation Study, Journal Article)
Copyright© The Author(s) 2015.
Chemical References
  • Antitubercular Agents
  • Biomarkers
Topics
  • Adolescent
  • Antitubercular Agents (therapeutic use)
  • Biomarkers (blood)
  • Child
  • Child, Preschool
  • Female
  • Humans
  • India
  • Infant
  • Lymphocytes (physiology)
  • Male
  • Monocytes (physiology)
  • Predictive Value of Tests
  • Retrospective Studies
  • Tuberculosis, Osteoarticular (blood, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: